...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >A single centre's experience of stereotactic radiosurgery and radiotherapy for non-functioning pituitary adenomas with the Linear Accelerator (Linac)
【24h】

A single centre's experience of stereotactic radiosurgery and radiotherapy for non-functioning pituitary adenomas with the Linear Accelerator (Linac)

机译:单个中心使用线性加速器(Linac)进行立体定向放射外科手术和放射治疗非功能性垂体腺瘤的经验

获取原文
获取原文并翻译 | 示例
           

摘要

Non-functioning pituitary adenomas are primarily a surgically managed pathology, but recurrence or regrowth is not uncommon. Previous large series have retrospectively validated the use of the Gamma Knife (GK) as an adjuvant treatment. To our knowledge, we present the largest case series to date with the Linear Accelerator (Linac) for the management of this pathology. In this study we review the clinical course of 118 patients, 51 of whom had stereotactic radiosurgery (SRS) and 67 who had fractionated stereotactic radiotherapy (FSRT); the discriminatory feature being proximity to the optic chiasm. For comparison purposes a population of 53 patients who had conventional radiotherapy (CRT) is included. The local control rates at 5 years for SRS, FRST and CRT were 100%, 93% and 87% respectively. Treatment-related morbidity was low. These data confirm that Linac SRS and FSRT are safe and effective for the treatment of non-functioning pituitary adenomas.
机译:非功能性垂体腺瘤主要是外科手术控制的病理,但复发或再生长并不罕见。以前的大型研究回顾性地验证了伽玛刀(GK)作为辅助治疗的用途。据我们所知,我们提供了迄今为止最大的线性加速器(Linac)病例系列来管理这种病理情况。在这项研究中,我们回顾了118例患者的临床病程,其中51例接受了立体定向放射外科手术(SRS),67例进行了立体定向放射治疗(FSRT)。歧视性特征是靠近视交叉。为了进行比较,纳入了接受常规放射治疗(CRT)的53名患者。 SRS,FRST和CRT在5年的本地控制率分别为100%,93%和87%。与治疗相关的发病率低。这些数据证实,Linac SRS和FSRT对于治疗无功能的垂体腺瘤是安全有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号